LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3401 | 4267 | 0.7967 | 0.7604 |
MCF7 | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3287 | 4267 | 0.7703 | 0.7280 |
MCF7 | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2897 | 4267 | 0.6791 | 0.6108 |
MCF7 | PD184352 | 10 | uM | LJP5 | 72 | hr | 1235 | 2074 | 4267 | 0.4856 | 0.3334 |
MCF7 | PLX-4720 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4683 | 4267 | 1.0972 | 1.1062 |
MCF7 | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3969 | 4267 | 0.9288 | 0.9152 |
MCF7 | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4133 | 4267 | 0.9681 | 0.9630 |
MCF7 | PLX-4720 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4186 | 4267 | 0.9820 | 0.9803 |
MCF7 | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3327 | 4267 | 0.7799 | 0.7402 |
MCF7 | PLX-4720 | 10 | uM | LJP5 | 72 | hr | 1235 | 2141 | 4267 | 0.5032 | 0.3604 |
MCF7 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2964 | 4056 | 0.7319 | 0.6659 |
MCF7 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3265 | 4056 | 0.8057 | 0.7630 |
MCF7 | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3706 | 4056 | 0.9130 | 0.8955 |
MCF7 | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3799 | 4056 | 0.9368 | 0.9254 |
MCF7 | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3964 | 4056 | 0.9764 | 0.9711 |
MCF7 | Lapatinib | 10 | uM | LJP6 | 72 | hr | 1235 | 2264 | 4056 | 0.5585 | 0.4232 |
MCF7 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2655 | 4056 | 0.6541 | 0.5607 |
MCF7 | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2650 | 4056 | 0.6532 | 0.5599 |
MCF7 | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2499 | 4056 | 0.6160 | 0.5064 |
MCF7 | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2650 | 4056 | 0.6531 | 0.5599 |
MCF7 | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2532 | 4056 | 0.6242 | 0.5193 |
MCF7 | Sirolimus | 10 | uM | LJP6 | 72 | hr | 1235 | 2605 | 4056 | 0.6421 | 0.5434 |
MCF7 | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3330 | 4056 | 0.8218 | 0.7833 |
MCF7 | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2292 | 4056 | 0.5656 | 0.4322 |
MCF7 | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1566 | 4056 | 0.3863 | 0.1483 |